<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public" slc-id="S1-BAI22084-DMV-4D-CCS"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>117 S3809 IS: Apply the Science Act</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2022-03-10</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">II</distribution-code><congress>117th CONGRESS</congress><session>2d Session</session><legis-num>S. 3809</legis-num><current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber><action><action-date date="20220310" legis-day="20220307">March 10 (legislative day, March 7), 2022</action-date><action-desc><sponsor name-id="S397">Mr. Braun</sponsor> (for himself and <cosponsor name-id="S411">Mr. Marshall</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSHR00">Committee on Health, Education, Labor, and Pensions</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title>To require the Comptroller General of the United States to conduct a study relating to COVID–19 immunity resulting from a prior infection, vaccination, or both, and the COVID–19 pandemic. </official-title></form><legis-body><section id="S1" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Apply the Science Act</short-title></quote>.</text></section><section id="idA6897BFDFD534C1BA3D0BBDC44874B3C"><enum>2.</enum><header>GAO study on natural immunity in relation to the COVID–19 pandemic</header><subsection id="id2e996c78e3e3408e8058b76c63279613"><enum>(a)</enum><header>Study</header><text>Not later than 180 days after the date of enactment of this Act, the Comptroller General of the United States shall conduct a study to determine the following:</text><paragraph id="id16d81be3adf447c19b3185c2dd8677b6" commented="no"><enum>(1)</enum><text>What is the current scientific understanding of the duration and effectiveness of COVID–19 immunity resulting from a prior infection, vaccination, or both, including any differences across population groups.</text></paragraph><paragraph id="id569f66bf44f34336bef015b1237e688e" commented="no"><enum>(2)</enum><text>To what extent does the Centers for Disease Control and Prevention make available, to key stakeholders, the body of work it has assessed to inform its policy decisions related to COVID–19 infection-acquired and vaccine-induced immunity.</text></paragraph><paragraph id="idb652fdddb2694240b32b86f3991b3d15" commented="no"><enum>(3)</enum><text>To what extent do select foreign countries take into account the scientific evidence pertaining to COVID–19 infection-acquired immunity when creating public health regulations or guidance.</text></paragraph><paragraph id="ida16b4233fc9046ae99f65af2498b6f45"><enum>(4)</enum><text>To what extent can diagnostic tests that measure the immune response be better utilized in a comprehensive COVID–19 response, including in high-risk population groups, and barriers to current use of these diagnostic tests. </text></paragraph></subsection><subsection id="id7858250a138d4d76b0e9eb98d84f70ab"><enum>(b)</enum><header>Report</header><text>Not later than 18 months after the date of enactment of this Act, the Comptroller General of the United States shall submit to the appropriate committees of Congress a report on the determinations made pursuant to subsection (a).</text></subsection></section></legis-body></bill> 

